Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Adjuvant therapy has been proved effective in treating earlier stage or less advanced non-small-cell lung cancer. This study is designed to evaluate the efficacy of icotinib as adjuvant therapy in treating stage II-IIIA non-small cell lung cancer patients with EGFR mutation. The primary endpoint is disease-free survival.
Critère d'inclusion
- non-small cell lung cancer